# Phase I Trial of Paclitaxel With Perifosine

> **NCT00399126** · PHASE1 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 24 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Perifosine
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00399126
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-01
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399126, "Phase I Trial of Paclitaxel With Perifosine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00399126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*